Search Results - "SANDANAYAKE, Neomal"

Refine Results
  1. 1
  2. 2
  3. 3

    Calcineurin inhibitors in steroid and anti‐TNF‐alpha refractory immune checkpoint inhibitor colitis by Zhang, Eva, Kiely, Christopher, Sandanayake, Neomal, Tattersall, Stephen

    Published in JGH open (01-05-2021)
    “…Background and Aim Immune checkpoint inhibitor (ICI) colitis is an increasingly common problem encountered as the use of checkpoint inhibitors (CPIs) grows in…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer by Dhar, Dipok Kumar, Olde Damink, Steven W.M., Brindley, James Hal, Godfrey, Andrew, Chapman, Michael H., Sandanayake, Neomal S., Andreola, Fausto, Mazurek, Sybille, Hasan, Tayyaba, Malago, Massimo, Pereira, Stephen P.

    Published in Cancer (01-02-2013)
    “…BACKGROUND: The early diagnosis of biliary tract cancer (BTC) remains challenging, and there are few effective therapies. This study investigated whether the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma by Chapman, Michael H, Tidswell, Robert, Dooley, James S, Sandanayake, Neomal S, Cerec, Virginie, Deheragoda, Maesha, Lee, Alvin J.X, Swanton, Charles, Andreola, Fausto, Pereira, Stephen P

    Published in Journal of hepatology (01-04-2012)
    “…Background & Aims Molecular analyses of biliary brushings using microarray and qPCR have the potential to provide valuable information on the biology of…”
    Get full text
    Journal Article
  9. 9

    Life-threatening diarrhea in neuroendocrine tumors: two case reports by Gordon, Emma, Chan, David L, Arena, Jennifer, Bernard, Elizabeth, Carr-Boyd, Emily, Clarke, Stephen J, Itchins, Malinda, Learoyd, Diana, Sandanayake, Neomal, Pavlakis, Nick

    Published in Journal of medical case reports (27-10-2021)
    “…Abstract Background Neuroendocrine tumors are rare, heterogeneous neoplasms that produce a wide variety of clinical symptoms. Diarrhea in neuroendocrine tumors…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer by Chapman, Michael H, PhD MRCP, Sandanayake, Neomal S, FRACP, Andreola, Fausto, PhD, Dhar, Dipok K, MBBS, Webster, George J, MD FRCP, Dooley, James S, MD FRCP, Pereira, Stephen P, PhD FRCP

    “…Abstract Background Biliary tract cancer (BTC) has a poor prognosis, in part related to difficulties in diagnosis. Cytokeratin 19 (CK19) is a constituent of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling by Sandanayake, Neomal S, Camuzeaux, Stephane, Sinclair, John, Blyuss, Oleg, Andreola, Fausto, Chapman, Michael H, Webster, George J, Smith, Ross C, Timms, John F, Pereira, Stephen P

    Published in BMC clinical pathology (04-02-2014)
    “…The aim of this discovery study was the identification of peptide serum biomarkers for detecting biliary tract cancer (BTC) using samples from healthy…”
    Get full text
    Journal Article
  15. 15

    R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer by Matull, Wolf-Rudiger, Dhar, Dipok K., Ayaru, Lakshmana, Sandanayake, Neomal S., Chapman, Michael H., Dias, Aruna, Bridgewater, John, Webster, George J. M., Bong, Jin J., Davidson, Brian R., Pereira, Stephen P.

    Published in Liver international (01-01-2011)
    “…Background: There is a need for better management strategies to improve the survival and quality of life in patients with biliary tract cancer (BTC). Aim: To…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20